ANLI(SZ:300218) Xin Lang Cai Jing·2025-11-10 06:17Core Viewpoint - Amway Co., Ltd. has experienced a decline in stock price and financial performance, with a notable drop in revenue and net profit year-on-year, indicating potential challenges ahead for the company [1][2]. Financial Performance - As of October 31, 2025, Amway reported a revenue of 1.679 billion yuan, a decrease of 6.84% year-on-year, and a net profit attributable to shareholders of 121 million yuan, down 19.22% year-on-year [2]. - The company's stock price has increased by 16.21% year-to-date but has seen a decline of 3.24% over the last five trading days, 3.61% over the last 20 days, and 25.82% over the last 60 days [1]. Shareholder Information - The number of shareholders increased by 4.84% to 17,000, while the average circulating shares per person decreased by 4.61% to 12,741 shares [2]. - The company has distributed a total of 341 million yuan in dividends since its A-share listing, with 131 million yuan distributed in the last three years [3]. Major Shareholders - As of September 30, 2025, the top ten circulating shareholders include new entrants such as Yongying Advanced Manufacturing Mixed Fund and Jiang Hai Securities, while several previous major shareholders have exited the list [3]. Business Overview - Amway specializes in the research, production, and sales of ecological functional polyurethane synthetic leather and composite materials, with 94.05% of its revenue coming from ecological functional synthetic leather [1]. - The company is classified under the basic chemical industry, specifically in plastics and other plastic products, and is associated with various concept sectors including sports industry and automotive components [1].